Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 9,900 shares, a growth of 7.6% from the November 30th total of 9,200 shares. Based on an average daily trading volume, of 690,100 shares, the short-interest ratio is presently 0.0 days. Currently, 0.2% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on Check-Cap in a research note on Friday, December 27th. They set a “sell” rating for the company.

Check-Cap Trading Down 2.5 %

Shares of Check-Cap stock traded down $0.02 on Thursday, reaching $0.97. 19,548 shares of the stock were exchanged, compared to its average volume of 257,456. The firm has a market capitalization of $5.65 million, a PE ratio of -0.32 and a beta of 0.25. Check-Cap has a 1-year low of $0.56 and a 1-year high of $3.45. The business has a fifty day moving average price of $0.94 and a two-hundred day moving average price of $1.51.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.